ADC THERAPEUTICS Trademark

Trademark Overview

On Monday, November 10, 2025, a trademark application was filed for ADC THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ADC THERAPEUTICS trademark a serial number of 99489063. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, April 17, 2026. This trademark is owned by ADC Therapeutics SA. The ADC THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention and treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies f...
adc therapeutics

General Information

Serial Number99489063
Word MarkADC THERAPEUTICS
Filing DateMonday, November 10, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, April 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention and treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans
Pseudo MarkANTIBODY DRUG CONJUGATE THERAPEUTICS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 10, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameADC Therapeutics SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressEpalinges 1066
CH

Trademark Events

Event DateEvent Description
Monday, November 10, 2025NEW APPLICATION ENTERED
Monday, November 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 10, 2025APPLICATION FILING RECEIPT MAILED
Friday, March 20, 2026ASSIGNED TO EXAMINER
Wednesday, March 25, 2026EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 25, 2026EXAMINERS AMENDMENT E-MAILED
Wednesday, March 25, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 25, 2026EXAMINER'S AMENDMENT ENTERED
Friday, April 17, 2026NON-FINAL ACTION WRITTEN
Friday, April 17, 2026NON-FINAL ACTION E-MAILED
Friday, April 17, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

therapeutics preparations immune pharmaceutical auto genetic rare diseases conditions disorders treatment